FerGene
About:
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals.
Website: https://www.fergene.com/
Top Investors: Ferring, Blackstone Group
Description:
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals. has been created to potentially commercialize nadofaragne firadenovec in the US and to advance the global clinical development.
Total Funding Amount:
$570M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Saint-prex, Vaud, Switzerland
Founded Date:
2019-11-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2019-11-25
IPO Status:
Private
© 2025 bioDAO.ai